Globex 2023: Market Recovery — Real or Driven by Inflation?

Globex 2023: Market Recovery — Real or Driven by Inflation?

September 22, 2023
September 22, 2023

Share

This article was originally published by UFI on September 22, 2023

Global exhibition market on track for strong recovery

In the latest edition of the Globex report, Stax forecasts the global exhibition market will exceed its 2019 pre-pandemic size by 7% in 2024, and 16% in 2025. Compared to the previous year’s edition, our forecasts have been largely revised upwards. The past year has witnessed a series of significant developments. The ramifications of the European energy crisis and escalating inflationary pressures have receded. China also lifted its zero-Covid policy ahead of schedule. Additionally, recessionary fears have been assuaged in most major markets. Coupled with the strong performance of face-to-face exhibitions, the dampening of these headwinds has resulted in a more positive outlook for the industry overall.

Nominal vs. real recovery – which should we trust?

These recovery numbers are impressive and make for good headlines. It does, however, beg the question of how much can be explained by higher-than-typical price rises, which have been commonplace at exhibitions over the past two years. When we look at Net Square Metre (NSM) volumes instead, the picture is quite different. Full NSM recovery is only expected to happen by 2025, 12-18 months behind nominal market recovery.


Comparing the evolution of the nominal and real market sizes, one might conclude the industry is not rebounding as strongly as headlines would suggest. This is only part of the picture. Another trend which has accelerated through the Covid period is the increase in share of non-stand revenues. Digital is the obvious one; while the industry’s experiment with monetising virtual shows has not succeeded, there is now greater adoption of complementary digital offerings which strengthen the face-to-face proposition. Sponsorship revenue is also gradually rising, particularly among organisers whose portfolios include multiple event formats and seek to diversify away from pure tradeshows.

Looking ahead

The impacts of inflation on sqm price rises are beginning to ease off. Broadly, market and organiser behaviour can be grouped into three categories:

  1. Dealing with persistent high inflation. Examples include Brazil and Türkiye. Inflation in these countries show no sign of receding to manageable levels, and organisers will continue to grapple with the challenge of passing cost rises to exhibitors. With the exception of market-leading shows with strong branding, imposing double-digit price hikes is not possible without jeopardising participation. We therefore expect continuing margin pressure on organisers.
  2. Recovering from high 2022-23 inflation. Examples include the U.S., U.K., France, and Germany. Organisers in these mature Western markets imposed price hikes up to 6-8% in 2022 and will see average NSM prices in 2025 remain c.15% higher than pre-Covid levels. Demonstrating enhanced ROI for exhibitors will be key for shows to continue growing.
  3. Catching up with Covid-era discounts. Examples include Hong Kong and Malaysia. These countries experienced strict Covid-driven restrictions in 2020-22 and had short periods of respite in between government-imposed lockdowns. To attract exhibitors during these limited periods of exhibition activities, organisers offered substantial discounts.

Clearly, there is no one-size-fits-all answer to the question of inflation. What is evident is that inflation must be taken into account when assessing the recovery of our industry.

About Stax and Globex

The Globex report is written by Stax’s team of strategy consultants and provides the market outlook to 2025 for 19 mature and emerging markets. More information can be found at https://www.stax.com/globex.

Read More

A Recap: Investing in Behavioral Health—Scalable Solutions for a Growing Need
July 14, 2025
Stax hosted healthcare-focused PE professionals in NYC to discuss a range of topics including scalable, tech-enabled behavioral health investments amid evolving care models and reimbursement. Click to learn more about what this event covered and how you can learn more.
Stax Perspective: AI Tools for K-12 Education
By Miriam El-Baz July 9, 2025
With AI education now a national priority, Miriam El-Baz highlights in her latest article how investor focus is shifting to classroom adoption and long-term, responsible impact. Learn more.
Stax Provides Sell-side Support to Bow River Capital on its Sale of Progressive Roofing to TopBuild
July 8, 2025
Stax congratulates Bow River Capital on the successful sale of Progressive Roofing, provider commercial roofing installation services, to TopBuild. Click here to read more.
A Plan in Need of a Plan—Early Reflections on the New 10-Year Plan for the NHS
By Adam Thorpe July 4, 2025
Following the release of the NHS 10-Year Plan yesterday, Stax explores what it means for independent sector providers and healthcare investors. Read more.
Featured by Reuters: How China's new auto giants left GM, VW and Tesla in the dust
By Phil Dunne July 3, 2025
In this recent Reuters special report, Phil Dunne highlights why automakers struggle to match Chinese carmakers—but still hold key advantages, especially in Europe. Click here to read more.
Featured by Carta: Tariffs bring uncertainty—and opportunities—for PE and M&A
By Robert Lytle July 2, 2025
Senior Managing Director Robert Lytle was featured by Carta in their latest article, discussing the impacts of tariffs on M&A and portfolio companies. Click here to read more.
Show More